Literature DB >> 669702

Triosephosphate isomerase deficiency with hemolytic anemia and severe neuromuscular disease: familial and biochemical studies of a case found in Spain.

J L Vives-Corrons, H Rubinson-Skala, M Mateo, J Estella, E Feliu, J C Dreyfus.   

Abstract

A 16-month-old girl of Spanish origin with chronic hemolytic anemia and severe neuromuscular disease was found to have markedly reduced triosephosphate isomerase (TPI) activity in her erythrocytes, leukocytes, and plateletes. Both parents and some other family members had moderately reduced erythrocyte TPI activity in accordance with the autosomal recessive mode of inheritance in this enzymopathy. Latex ingestion and latex-stimulated histochemical NBT reduction by the patient's granulocytes were normal. Zymosan-stimulated superoxide radical (O-.2) formation, not previously studied in TPI-deficient granulocytes, was also within normal limits. Starchgel electrophoresis of TPI in both erythrocytes and leukocytes of the proposita and her parents was normal. Molecular studies of deficient TPI showed a normal kinetic pattern with markedly reduced heat instability. Immunologic studies demonstrated no cross reacting material in proposita leukocytes and a normal molecular specific activity. These studies suggest that molecular instability might cause both enzymatic and antigenic degradation of the TPI molecule and, therefore, TPI deficiency in our patient.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 669702     DOI: 10.1007/BF00283637

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  HEREDITARY HEMOLYTIC ANEMIA WITH TRIOSEPHOSPHATE ISOMERASE DEFICIENCY.

Authors:  A S SCHNEIDER; W N VALENTINE; M HATTORI; H L HEINS
Journal:  N Engl J Med       Date:  1965-02-04       Impact factor: 91.245

2.  The glutathione instability of drug-sensitive red cells; a new method for the in vitro detection of drug sensitivity.

Authors:  E BEUTLER
Journal:  J Lab Clin Med       Date:  1957-01

3.  Glucose phosphate isomerase deficiency with hereditary hemolytic anemia in a Spanish family: clinical and familial studies.

Authors:  J L Vives-Corrons; C Rozman; A Kahn; A Carrera; J Triginer
Journal:  Humangenetik       Date:  1975-10-07

4.  A newly defined X-linked trait in man with demonstration of the Lyon effect in carrier females.

Authors:  D B Windhorst; B Holmes; R A Good
Journal:  Lancet       Date:  1967-04-08       Impact factor: 79.321

5.  Comparison of the electrophoretic properties of triosephosphate isomerases of various tissues and species.

Authors:  R M Snapka; T H Sawyer; R A Barton; R W Gracy
Journal:  Comp Biochem Physiol B       Date:  1974-12-15

Review 6.  [Acquired granulocyte disorders].

Authors:  J Hakim; P Boivin; J Boucherot; H Troube
Journal:  Nouv Rev Fr Hematol       Date:  1974 Mar-Apr

Review 7.  Deficiencies associated with Embden-Meyerhof pathway and other metabolic pathways.

Authors:  W N Valentine
Journal:  Semin Hematol       Date:  1971-10       Impact factor: 3.851

8.  [Acquired erythroenzymopathies. I. Quantitative anomalies observed in 100 cases of various hemopathies].

Authors:  P Boivin; C Galand; M Audollent
Journal:  Pathol Biol (Paris)       Date:  1970-02

9.  A new isozyme of triose phosphate isomerase specific to hominoids.

Authors:  H Rubinson; M C Meienhofer; J C Dreyfus
Journal:  J Mol Evol       Date:  1973-11-27       Impact factor: 2.395

10.  Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes.

Authors:  J T Curnutte; B M Babior
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

View more
  16 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Characterization of the functional gene and several processed pseudogenes in the human triosephosphate isomerase gene family.

Authors:  J R Brown; I O Daar; J R Krug; L E Maquat
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

3.  Prevalence of partial deficiency of red cell triosephosphate isomerase in Germany--a study of 3000 people.

Authors:  S W Eber; M Dünnwald; G Heinemann; T Hofstätter; H M Weinmann; B H Belohradsky
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  Hereditary triose phosphate isomerase deficiency: seven new homozygous cases.

Authors:  R Rosa; M O Prehu; M C Calvin; J Badoual; D Alix; R Girod
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Triosephosphate isomerase deficiency: haemolytic anaemia, myopathy with altered mitochondria and mental retardation due to a new variant with accelerated enzyme catabolism and diminished specific activity.

Authors:  S W Eber; A Pekrun; A Bardosi; M Gahr; W K Krietsch; J Krüger; R Matthei; W Schröter
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

6.  Characterization of two new electrophoretic variants of human triosephosphate isomerase: stability, kinetic, and immunological properties.

Authors:  J Asakawa; H W Mohrenweiser
Journal:  Biochem Genet       Date:  1982-02       Impact factor: 1.890

7.  Electrophoretic variants of blood proteins in Japanese. III. Triosephosphate isomerase.

Authors:  J Asakawa; C Satoh; N Takahashi; M Fujita; J Kaneko; K Goriki; R Hazama; T Kageoka
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

8.  Characterization of triosephosphate isomerase mutants with reduced enzyme activity in Mus musculus.

Authors:  S Merkle; W Pretsch
Journal:  Genetics       Date:  1989-12       Impact factor: 4.562

9.  Hereditary triosephosphate isomerase (TPI) deficiency: two severely affected brothers one with and one without neurological symptoms.

Authors:  S Hollán; H Fujii; A Hirono; K Hirono; H Karro; S Miwa; V Harsányi; E Gyódi; M Inselt-Kovács
Journal:  Hum Genet       Date:  1993-11       Impact factor: 4.132

10.  Human triose-phosphate isomerase deficiency: a single amino acid substitution results in a thermolabile enzyme.

Authors:  I O Daar; P J Artymiuk; D C Phillips; L E Maquat
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.